Literature DB >> 2812836

Pharmacokinetics of fentanyl in lumbar and cervical CSF following lumbar epidural and intravenous administration.

Geoffrey K Gourlay1, Terence M Murphy, John L Plummer, Stefan R Kowalski, David A Cherry, Michael J Cousins.   

Abstract

Fentanyl (1 microgram/kg body weight) was administered intravenously and via a lumbar epidural catheter (in random order) on 2 separate occasions to 6 patients with chronic pain associated with non-terminal disease states. Frequent blood samples were collected from an indwelling intravenous catheter and CSF samples were collected via spinal needles inserted in the cervical (C7-T1 interspace) and lumbar (L3.4 interspace) regions at 0, 5, 10, 20, 30 and 45 min after fentanyl administration. The concentration of fentanyl in blood and CSF samples were quantified by a sensitive and selective gas-liquid chromatography assay. Visual analogue pain scores (VAPS) were recorded every 5 min for the first hour. Coded syringes (one containing the appropriate fentanyl dose while the other contained an equivalent volume of saline) allowed the investigator administering the fentanyl and assessing VAPS to remain blinded as to which route of administration actually contained the fentanyl. There was minimal vascular uptake of fentanyl following epidural administration. Similarly, the permeation of fentanyl into cervical and lumbar CSF following intravenous administration was minimal and erratic such that only 4 of the 60 CSF samples had detectable fentanyl concentrations. In contrast, there was a rapid penetration of fentanyl across the dura mater following lumbar epidural administration. There was significantly fentanyl in lumbar CSF samples by 10 min in 5 patients, and by 20 min in all 6 patients. The mean maximum lumbar CSF concentration was 19.1 ng/ml, while the time associated with these maximum concentrations was 22.5 min. The mean maximum cervical CSF fentanyl concentrations were 10% of the lumbar CSF concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2812836     DOI: 10.1016/0304-3959(89)90210-8

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  21 in total

1.  Respiratory depression following a cervical epidural opioid injection.

Authors:  K Mizuyama; S Watanabe
Journal:  J Anesth       Date:  1991-10       Impact factor: 2.078

2.  Side effects during continuous epidural infusion of morphine and fentanyl.

Authors:  M J White; E J Berghausen; S W Dumont; K Tsueda; J A Schroeder; R L Vogel; M F Heine; K C Huang
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

3.  Epidural Techniques for Cancer Pain Management: When, Why, and How?

Authors: 
Journal:  Curr Rev Pain       Date:  1999

4.  Nystagmus caused by epidural fentanyl.

Authors:  Byung Gun Lim; Jea Yeun Lee; Heezoo Kim; Dong Kyu Lee; Mi Kyoung Lee
Journal:  J Anesth       Date:  2011-10-27       Impact factor: 2.078

5.  Epidural opioids for post-thoracotomy pain.

Authors:  R P Grant
Journal:  Can J Anaesth       Date:  1994-03       Impact factor: 5.063

6.  Can parturients distinguish between intravenous and epidural fentanyl?

Authors:  G F Morris; W Gore-Hickman; S A Lang; R W Yip
Journal:  Can J Anaesth       Date:  1994-08       Impact factor: 5.063

7.  A comparison of lumbar epidural and intravenous fentanyl infusions for post-thoracotomy analgesia.

Authors:  A D Baxter; S Laganière; B Samson; J Stewart; K Hull; L Goernert
Journal:  Can J Anaesth       Date:  1994-03       Impact factor: 5.063

8.  Intratracheal administration of fentanyl: pharmacokinetics and local tissue effects.

Authors:  J E Irazuzta; U Ahmed; A Gancayco; S T Ahmed; J Zhang; K J Anand
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

9.  Complications of continuous epidural infusions for postoperative analgesia in children.

Authors:  C E Wood; G V Goresky; K A Klassen; B Kuwahara; S G Neil
Journal:  Can J Anaesth       Date:  1994-07       Impact factor: 5.063

10.  Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans.

Authors:  Markus Amann; Lester T Proctor; Joshua J Sebranek; David F Pegelow; Jerome A Dempsey
Journal:  J Physiol       Date:  2008-11-17       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.